Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
5h agoDelivery Hero confirms approach by Uber Technologies’ with respect to potential takeover offer
6h agoRefers to Item 7 on the agenda: Report on the audit of the consolidated financial statements of Grupa Kęty SA
8h agoThe 4th BOCHK Science and Technology Innovation Prize Award Ceremony Concludes with Great Success
15h agoBuffalo Potash Files Annual Information Form and New Technical Report
16h agoIonik Announces 30-Day Extension of Senior Debt Facility
Oryzon Genomics Sa logo

Oryzon Genomics Sa

About

3.03EUR+0.00 +0.07%
Closed • Updated at 19:00 GMT+00:00
Market Cap$277.35M
Volume372.3K
Beta0.66
RSI66.98
Health TechnologyBiotechnology

Oryzon Genomics Sa — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 29 2026
ORYZON to Participate in Upcoming Events in May and June
Mar 25 2026
ORYZON Strengthens Vafidemstat Patent Portfolio With U.S. Notice of Allowance
Mar 23 2026
ORYZON Announces U.S. Patent Grant Covering Iadademstat Combinations with Venetoclax
Mar 12 2026
ORYZON Expands Patent Protection for Iadademstat with Grant Decision in Mexico Covering Combinations with PD-1/PD-L1 Inhibitors
Feb 27 2026
ORYZON Reports Financial Results and Corporate Update for Quarter Ended December 31st, 2025

Community Chat

Ask AI

6ix6ixAIEvents